JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Studies about the bioactive component analysis and an oral glucose tolerance test of Add-Omit-Saenghyeoryunbu-eum(AO-SHU) for confirmation of diabetes therapy
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : Herbal Formula Science
  • Volume 24, Issue 2,  2016, pp.80-99
  • Publisher : The Korean Journal of Oriental Medical Prescription
  • DOI : 10.14374/HFS.2016.24.2.80
 Title & Authors
Studies about the bioactive component analysis and an oral glucose tolerance test of Add-Omit-Saenghyeoryunbu-eum(AO-SHU) for confirmation of diabetes therapy
In, Jeongdo; Im, Daisig; Kim, Won-Ill;
  PDF(new window)
 Abstract
Objectives : Instrumental chemical analysis was utilized to investigate the effect of Add-Omit-Saenghyeoryunbu-eum(AO-SHU) on diabetic treatment. One of the most exciting, yet also controversial, arguments is the safety and biological mechanisms of the natural medicine on human body. Therefore, the aim of this study is to provide a better understanding on bioactive chemical components, hazards of heavy metal contamination and biological mechanism of the diabetic medicine composed of 12 different natural herbs. Methods : To study bioactive compound and metallic component in the diabetic medicine in detail, LC-MS/MS (Liquid Chromatography-Mass/Mass), GC (Gas Chromatography) and ICP (Inductively Coupled Plasma) were utilized to characterize the extract of the diabetic medicine and the result was compared with 18 marker substances selected from literature survey. In addition, in vitro assay experiments including GPR 119 activity and human DGAT-1 inhibition, and OGTT (Oral Glucose Tolerance Test) were performed to verify the effectiveness of this medicine on diabetic treatment. Results : Out of 18 marker substances, 9 bioactive compounds were identified from LC-MS/MS analysis which include Citruline, Catalpol, Berberine, Ginsenoside Rb1, Ginsenoside Rg1, Oleanolic acid, β-Sitosterol, Mangiferin, and Schizandrin. ICP study on 245 residual pesticides revealed that 239 species were not detected but 6 species, Dimethomorph, Trifloxystrobin, Pyraclostrobin, Isoprocarb, Carbaryl and Flubendiamide, while the amounts are trace levels, below permitted concentrations. The biological activity was observed in vitro assay and Oral Glucose Tolerance Test(OGTT), which are consistent with a preliminary clinical test result, a drop in blood sugar level after taking this herbal medicine. Conclusions : Instrumental chemical analysis using LC-MS/MS, GC, and ICP was conducted successfully to identify bioactive compounds in AO-SHU for the treatment of diabetes, finding 9 bioactive compounds. Furthermore, in vitro assay experiments and OGTT show that AO-SHU has its biological activities, which imply that it can be a candidate for the future diabetes remedy.
 Keywords
Add-Omit-Saenghyeoryunbu-eum(AO-SHU);Diabetes Therapy;Pharmacological active ingredient;Instrumental analysis;OGTT;
 Language
Korean
 Cited by
 References
1.
Nephrology of Korean Medicine association. Nephrology of Korean Medicine. Seoul: Gunja press; 2011, p. 94-5, 300-9.

2.
International Diabetes Federation. "IDF launches WDD 2015 campaign at WHA side event" 2015.

3.
Statistical Office. 2012 Cause of Death Statistics. Press release, 2013.

4.
M Khattab, YS Khader, A. A. Al-Khawaldeh, and K. Ajlouni. Factors associated with poor glycemic control among patients with type 2 diabetes. Journal of Diabetes and Its Complications. 2010;24(2):84-9. crossref(new window)

5.
Kim DH, Park SC, Lee JH, Lee HY, Cho MK, Choi JY, Kim SY, Park SH. Recent Research Trends in Korean Medicine Treatment of Diabetes Mellitus - Focusing on Domestic Articles from 2008 to 2013. Journal of Korean Internal Medicine 2013:34(3):240-55.

6.
Huhjun. Dongeuibogam. Seoul: Namsan-Dang; 1990, p. 417, 615, 781-5.

7.
In JD, Im DS, Moon SH, Kim WI. Characteristic Effects of Dangnyo-hwan for Diabetes Control Studied Using LC-MS/MS and ICP. Journal of Korean Internal Medicine 2015:36(3):217-27.

8.
WL Li, HC Zheng, J Bukuru, ND Kimpe. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. Journal of Ethnopharmacology 2004;92:1-21. crossref(new window)

9.
JK Grover, S Yadav, V Vats. Medicinal plants of India with anti-diabetic potential. Journal of Ethnopharmacology 2002;81:81-100. crossref(new window)

10.
Adolfo AC, Michael H. Mexican plants with hypoglycaemic effect used in the treatment of diabetes. Journal of Ethnopharmacology 2005;99:325-48. crossref(new window)

11.
Pulok K. Mukherjee KM, Kakali M, Peter JH. Leads from Indian medicinal plants with hypoglycemic potentials. Journal of Ethnopharmacology 2006;106:1-28. crossref(new window)

12.
Hjroshj H, Miki Y, Yutaka S, Yoshiteru Oa, Chohachi K. Isolation and Hypoglycemic Activity of Trichosans A, B, C, D, and E: Glycans of Trichosanthes kirilowii Roots. Planta Medica 1989;55:349-50. crossref(new window)

13.
Lee KH et al. Anti-Microbial and Anti-Wrinkle Effect of Kaempferol and Kaempferol Rhamnosides isolated from Hibiscus cannabinus L. Korean J. Medicinal Crop Sci 2012;20(6):454−60. crossref(new window)

14.
GY Lee. Cucurbitacin Contents in Cucurbits Influenced by Crops, Organs, and Cultural Practices. Doctorate thesis, Kyunghee Univ, 2010.

15.
ZHANG LJ, JIANG HZ. Present State and Prospect of Clinical Application of Trichosanthin. CJIM 1996;2(2):157-9.

16.
Pushpa N, Nai KM, Phuong BL, Ricky NS. Isolation and characterization of new isoforms of trichosanthin from Trichosanthes kirilowii. Plant Science 2002;162:79-85. crossref(new window)

17.
Hwang SJ, Na MS. Optimal Culture Conditions for Transformed Root Growth and Trichosanthin Formation in Trichosanthes kirilowii Max, Korean J. Medicinal Crop Sci 2007;15(1):46-50.

18.
Yoo BR et al. Catalpol Content and Antioxidant Activities in Various Cultivars of Rehmannia glutinosa. Korean Soc Food Sci Nutr 2011;40(4):481-5. crossref(new window)

19.
KY Lee et al. Cognitive-enhancing Activity of Loganin Isolated from Cornus officinalis in Scopolamine-induced Amnesic Mice. Arch Pharm Res 2009;32(5):677-83. crossref(new window)

20.
Song TJ. Antidiabetic Activities of Betulinic Acid by Activation of AMPK Pathway. Master's thesis, Handong Univ, 2010.

21.
Yun MS et al. Antitumor Effect of Schizandrin by Inhibiting Angiogenesis. Korean J. Oriental Physiology & Pathology 2012;26(5):687-92.

22.
Sung HJ et al. Antioxidant Effects of Sesamin and Sesamolin in Streptozotocin-induced Diabetes Mellitus Rat. J. Fd Hyg. Safety 2001;16(4):349-54.

23.
Kim GS et al. Isolation and HPLC Analysis of Timosaponin A III from Rhizomes of Anemarrhena asphodeloides BUNGE. Korean J. Medicinal Crop Sci 1999;7(1):45-50.

24.
Choi BC. Pharmacokinetic changes of Diltiazem, Tolbutamide and Sulfamethoxazole after oral administration to rabbits with Alloxan-induced diabetes mellitus. Doctorate thesis, Chosun Univ, 2000.

25.
Brown AJ. Novel cannabinoid receptors. British Journal of Pharmacology 2007;152(5):567-75.

26.
Overton HA, Fyfe MC, Reynet C. GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity. British Journal of Pharmacology 2008;153:S76-81.

27.
Ann JH et al. Thienopyrimidine derivatives, pharmaceutically acceptable salt thereof preparation method thereof and pharmaceutical composition for prevention or treatment of diabetes-related disease containing the same as an active ingredient. KR patent, 1014014960000, 2012.

28.
Cases S, Smith SJ, Zheng YW, Myers HM, Lear SR, Sande E, Novak S, Collins C, Welch CB, Lusis AJ, Erickson SK, Farese RV. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc. Natl. Acad. Sci. U.S.A 1998;95(22):13018-23. crossref(new window)

29.
Chen HC, Farese RV. Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2005;25(3):482-6. crossref(new window)

30.
A Giaccari, G Sorice, G Muscogiuri. Glucose toxicity: The leading actor in the pathogenesis and clinical history of type 2 diabetes- mechanisms and potentials for treatment, Nutrition. Metabolism and Cardiovascular Diseases 2009;19(5):365-77. crossref(new window)

31.
Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, Lee L, Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA 1994;91:12013-17. crossref(new window)

32.
Marin JA, Maciel BC, Secches AL, Gallo JL. Cardiovascular effects of berberine in patients with severe congestive heart failure. Clinical Cardiology 1988;11(4):253-60. crossref(new window)

33.
Zhou JY, Zhou SW, Zhang KB, Tang JL, Guang LX, Ying Y et al. Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats. Biological & Pharmaceutical Bulletin 2008;31(6):1169-76. crossref(new window)

34.
Gu L, Li N, Gong J, Li Q, Zhu W, Li J. Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia. The Journal of infectious diseases 2011;203(11):1602-12. crossref(new window)

35.
Kuo CL, Chi CW, Liu TY. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 2004;203(2):127-37. crossref(new window)

36.
Zhou J, Zhou S, Tang J et al. Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats. Eur J Pharmacol 2009;606:262-8. crossref(new window)

37.
Yin J, Gao Z, Liu D, Liu Z, Ye J. Berberine improves glucose metabolism through induction of glycolysis. Am. J. Physiol. Endocrinol. Metab 2008;294:E148-56.

38.
Liu L, Yu YL, Yang JS et al. Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study. Naunyn Schmiedebergs Arch Pharmacol 2010;381:371-81. crossref(new window)

39.
Pan GY, Huang ZJ, Wang GJ, Fawcett JP, Liu XD, Zhao XC, Sun JG, Xie YY. The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Medica 2003;69:632-6. crossref(new window)

40.
Lee WS. Vegetable of Korea. Daegu: Kyungbuk National University Press; 1994, pp. 189-202.

41.
Rudkowska I, AbuMweis SS, Nicolle C, Jones PJ. Cholesterol-lowering efficacy of plant sterols in low-fat yogurt consumed as a snack or with a meal. J Am Coll Nutr 2008;27(5):588-95. crossref(new window)

42.
Park EH, Kahng JH, Lee SH, Shin KH. An anti-inflammatory principle from cactus. Fitoterapia 2001;72:288-90. crossref(new window)

43.
Basnet P, Kadota S, Terashima S, Shimizu M, Namba T. Two new 2-arylbenzofuran derivatives from hypoglycemic activity-bearing fractions of Morus insignis. Chemical and Pharmaceutical Bulletin 1993;41:1238-43. crossref(new window)

44.
Yu BC, Hung CR, Chen WC, Cheng JT, Antihyperglycemic effect of andrographolide in streptozotocin-induced diabetic rats. Planta Medica 2003;69:1075-9. crossref(new window)

45.
Kim TH, Lim HJ, Kim MS, Lee MS. Dietary supplements for benign prostatic hyperplasia: An overview of systematic reviews. Maturitas 2012;73(3):180-5. crossref(new window)

46.
Dinda B, Debnath S. Harigaya Y. Naturally Occurring Iridoids. A Review, Part 1. Chemical & Pharmaceutical Bulletin 2007;55(2):159-222. crossref(new window)

47.
Huang WJ, Niu HS, Lin MH, Cheng JT, Hsu FL. Antihyperglycemic effect of catalpol in streptozotocin-induced diabetic rats. J Nat Prod 2010;73:1170-2. crossref(new window)

48.
Tian YY, An LJ, Jiang L, Duan YL, Chen J, Jiang B. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures. Life Sci 80:193-9. crossref(new window)

49.
Liu J1, He QJ, Zou W, Wang HX, Bao YM, Liu YX, An LJ. Catalpol increases hippocampal neuroplasticity and up-regulates PKC and BDNF in the aged rats. Brain Res 2006;1123(1):68-79. crossref(new window)

50.
Stoilova I, Gargova S, Stoyanova A, Ho L. Antimicrobial and Antioxidant Activity of the Polyphenol Mangiferin. Herba Polonica 2005; 51(1/2):37-44.

51.
Wang X, Liao J, Yin D, Zhan F, Dai S, Xie G, Sang X. Establishment of a Novel Model for Studying the Effects of Extracts of Chinese Herb Medicine on Human Type II 5-alpha-Reductase in Vitro. Journal of the Pharmaceutical Society of Japan 2010;130(9):1207-14.

52.
Carvalho A, Guedes M, Souza A, Trevisan M, Lima A, Santos F, Rao V. Gastroprotective Effect of Mangiferin, a Xanthonoid from Mangifera indica, against Gastric Injury Induced by Ethanol and Indomethacin in Rodents. Planta Medica 2007;73(13):1372-6. crossref(new window)

53.
Miura T, Ichiki H, Hashimoto I, Iwamoto N, Kato M, Kubo M, Ishihara E et al. Antidiabetic Activity of a Xanthone Compound, Mangiferin. Phytomedicine 2001;8(2):85-7. crossref(new window)

54.
Ichiki H, Iwamoto N, Kato M, Kubo M, Sasaki H, Okada M et al. Antidiabetic activity of the rhizoma of Anemarrhena asphodeloides and active components, mangiferin and its glucoside. Biological & Pharmaceutical Bulletin 2001;24:1009-11. crossref(new window)

55.
Miura T, Ichiki H, Hashimoto I, Iwamoto N, Kato M, Kubo M et al. Antidiabetic activity of a xanthone compound, mangiferin. Phytomedicine 2001;8:85-7. crossref(new window)

56.
Muruganandan S, Srinivasan K, Gupta S, Gupta PK, Lal J. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. Journal of Ethnopharmacology 2005;97:497-501. crossref(new window)

57.
SH Lee, JY Hu, EH Lee, SY Kim. Ginsenoside Rb1 modulates level of monoamine neurotransmitters in mice frontal cortex and cerebellum in response to immobilization stress. Biomolecules&Therapeutics 2012; 20(5):482-6. crossref(new window)

58.
Chan RY, Chen WF, Dong A, Guo D, Wong MS. Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng. J Clin Endocrinol Metab 2002;87(8):3691-5. crossref(new window)

59.
Milbury PE, Richer AC. Understanding the Antioxidant Controversy: Scrutinizing the "fountain of Youth". Greenwood Publishing Group; 2008, p. 99.